Enanta Pharmaceuticals
ENTA
#7684
Rank
ยฃ0.27 B
Marketcap
ยฃ9.43
Share price
0.00%
Change (1 day)
124.20%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Net assets

Net assets on the balance sheet as of September 2025 : ยฃ47.3 Million

According to Enanta Pharmaceuticals 's latest financial reports the company has ยฃ47.3 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2025-09-30$ยฃ48.14 M-50.01%
2024-09-30$ยฃ96.3 M-45.81%
2023-09-30$ยฃ0.17 B-38.47%
2022-09-30$ยฃ0.28 B-2.61%
2021-09-30$ยฃ0.29 B-15.92%
2020-09-30$ยฃ0.35 B-6.28%
2019-09-30$ยฃ0.37 B24.64%
2018-09-30$ยฃ0.30 B34.07%
2017-09-30$ยฃ0.22 B8.13%
2016-09-30$ยฃ0.20 B33.37%
2015-09-30$ยฃ0.15 B70.31%
2014-09-30$ยฃ91.68 M34.35%
2013-09-30$ยฃ68.24 M150.5%
2012-09-30$ยฃ27.24 M93.8%
2011-09-30$ยฃ14.05 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
ยฃ57.95 B 122,397.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ32.71 B 69,050.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
-ยฃ1.9 Billion-4,115.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ12.66 B 26,660.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ37.94 B 80,106.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ13.59 B 28,640.52%๐Ÿ‡บ๐Ÿ‡ธ USA